Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
MPM Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
MPM Capital

MPM Capital

Operating

MPM Capital L.P. is a US-based healthcare investment firm, specializing in venture capital for therapeutic areas.

Location
Boston, MA, US
Founded
1996
Firm
Compare
Portfolio
Employees
Website

MPM Capital L.P. is a US-based healthcare investment firm specializing in venture capital for therapeutic areas. The firm invests in both private and public biotech companies that are developing innovative, life-saving drugs. MPM Capital typically engages in Series A through Series E funding rounds, with a significant focus on early-stage investments, including seed rounds.

Notable portfolio companies include 23andMe, Acorda Therapeutics, and ElevateBio. The firm is led by experienced partners who bring a wealth of knowledge from previous affiliations with leading biotech and pharmaceutical companies. MPM Capital offers unique value-add services such as strategic guidance and industry connections to help portfolio companies navigate the complex landscape of drug development and commercialization.

MPM Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments127
Current Portfolio Count54
Total Portfolio Exits6

Top Investment Stages

Series A42 (36.8%)
Series B34 (29.8%)
Series C17 (14.9%)
Series Unknown12 (10.5%)
Series D9 (7.9%)

Stage Mix

Series A 37%Series B 30%Series C 15%Series Unknown 11%Series D 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Deka Biosciences logo

Deka Biosciences

ReCode Therapeutics logo

ReCode Therapeutics

Arialys Therapeutics logo

Arialys Therapeutics

Crossbow Therapeutics logo

Crossbow Therapeutics

ElevateBio logo

ElevateBio

ReNAgade Therapeutics logo

ReNAgade Therapeutics

NextPoint Therapeutics logo

NextPoint Therapeutics

Photys Therapeutics logo

Photys Therapeutics

Aktis Oncology logo

Aktis Oncology

Orna Therapeutics logo

Orna Therapeutics

Coda Biotherapeutics logo

Coda Biotherapeutics

Protego Biopharma logo

Protego Biopharma

Frontier Medicines logo

Frontier Medicines

Entrada Therapeutics logo

Entrada Therapeutics

Werewolf Therapeutics logo

Werewolf Therapeutics

Cullinan Oncology logo

Cullinan Oncology

Umoja Biopharma logo

Umoja Biopharma

iTeos Therapeutics logo

iTeos Therapeutics

BioIntervene logo

BioIntervene

Triplet Therapeutics logo

Triplet Therapeutics

SiO2 Medical Products logo

SiO2 Medical Products

Amphivena Therapeutics logo

Amphivena Therapeutics

Twentyeight-Seven Therapeutics logo

Twentyeight-Seven Therapeutics

Iconic Therapeutics logo

Iconic Therapeutics

Tetherex Pharmaceuticals logo

Tetherex Pharmaceuticals

MPM Capital - Similar Investment Firms

MP Healthcare Venture Management logo

MP Healthcare Venture Management

mp-healthcare.com

BioImpact Capital logo

BioImpact Capital

MVM Partners logo

MVM Partners

mvm.com

Foresite Capital logo

Foresite Capital

Versant Ventures logo

Versant Ventures

Venrock Healthcare Capital Partners logo

Venrock Healthcare Capital Partners

Pappas Capital logo

Pappas Capital

pappas-capital.com

Mass Medical Angels logo

Mass Medical Angels

massmedangels.com

March Capital logo

March Capital

marchcp.com

Samsara BioCapital logo

Samsara BioCapital

samsaracap.com

Mission Bay Capital logo

Mission Bay Capital

Bioventures Investors logo

Bioventures Investors

Mission BioCapital logo

Mission BioCapital

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Biomatics Capital Partners logo

Biomatics Capital Partners

MPM Capital - Classification

Also Known As
  • MPM Capital, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end